Novartis settles one of two MS drug patent disputes
Action against generics group Mylan continues after terms agreed with rival generics player Accord Healthcare in patent infringement case
Mylan
Some 70 jobs to go at pharmaceutical company Viatris in north Dublin
Job losses form part of global restructuring
Plan to close Dublin pharma plant with loss of 440 jobs a ‘devastating blow’
Viatris generic medicines facility in Baldoyle due to shut down over next two years
Pfizer’s Upjohn spin-off completes merger with Mylan to form Viatris
Merged entity becomes largest player in global generic pharmaceuticals market
European shares end lower on fears of ‘second wave’ of Covid-19
Stoxx 600 weighed down by Wirecard over missing $2.1bn in payments firm’s accounts
Mylan beats profit on stockpiling of cold and asthma medicines
Generics group ramps up production of old malaria drug, named by Trump as Covid-19 therapy
Job postings decline by half due to impact of Covid-19, recruiter says
Pharma and IT sectors need more staff due to drug development and remote working
Covid lockdowns to hit profits at drug giants Pfizer and Merck
Keytruda parent lowers full-year forecasts while Pfizer expects recovery in second half of year
Medical supplies strong as EU announces €50m stockpile of equipment
New stockpile will be available to Member States fighting impact of coronavirus
Cliff Taylor: Coronavirus means Ireland's economic outlook hangs in the balance
Supplies and health pose risks parallel to Brexit and require new financial forecasts
Your business week: Election-hit Bank of Ireland to report results
Salesforce, Glanbia and CRH to report; Guaranteed Irish roadshow on future trends takes place in UCC
Pfizer pulls plug on pension reforms after union rejection
Drug giant warns managing costs in Ireland remains a ‘significant business challenge’
This Week in Business: Media and aviation giants report results
Darina Allen talks to women who don’t lunch, while the FT’s Martin Wolf talks transformation
Pfizer boosted by innovative drugs and emerging markets growth
Pharma company delivers rosier guidance as it focuses on branded drugs
Weak sterling boosts FTSE as markets elsewhere await US Fed decision
Markets report: Aryzta continues slide in Dublin; Bank of Ireland, Ryanair fall
Pfizer and Mylan to combine off-patent drugs businesses
Deal between makers of EpiPens and Viagra will create group with global annual revenues worth €18bn
Pfizer expected to announce stock deal with Mylan
Deal would cover former blockbuster brands like Lipitor and Viagra, both made in Ireland
European shares end lower as Fed optimism short-lived
Markets report: Airbus rises after strong delivery numbers, Superdry slumps to a loss
European shares drop on growth and trade concerns
Dalata and Ryanair both lost ground, while Irish banking stocks were in favour
Business This Week: results, indicators and meetings
Ibec to host its European election debates and IFG shareholders vote on takeover
Indivior shares tank after US indictment for illegal marketing
Shares in British maker of opioid addiction treatment Suboxone fell more than 70%
All eyes on loan growth as Bank of Ireland reports full-year results
This Week: Big week for banks as SME lending stays weak amid Brexit caution
State fails to save millions on HSE medicines bill
Lobbyists call for extending use of cheaper ‘copycat’ drugs where available
This Week in Business: Blair to address Web Summit Lisbon
National Analytics Conference takes place in Dublin, results due from Liberty Media
HSE may miss out on €37m savings as costly drug Humira comes off patent
Policy of switching to biosimilar drugs never adopted
Ryanair lobbies on tax, Tyrone firm urges staff to get Irish passports and what next for the NBP?
Business Today: the best news, analysis and comment from ‘The Irish Times’ business desk
Mylan claims HSE could save €42m with use of biosimilar drug for arthritis
Company plans to introduce generic version of Humira either later this year or early in 2019
European shares dip amid ongoing trade tensions
Markets report: Iseq down almost 0.8% as Aryzta hits fresh low
Mylan says US healthcare market is ‘unsustainable’
Generic drugs giant falls far short of Wall Street forecasts with second-quarter profit
This Week: Results from KBC, Glanbia and Kerry Group
Figures for car sales in July to give pointer to performance for remainder of year
Rural broadband plan looks offline, Brexit strategy shambles and Love Island
Business Today: the best news, analysis and comment from ‘The Irish Times’ business desk
Mylan urges Government to boost take-up of biosimilars
Drugmaker says approving more biosimilar drugs for use here could save the State €140m a year
Drug patent protection regime needs to change
The public can’t continue to pay for the inaction of policymakers
European court decision may lead to more affordable access to HIV drug
Biopharma firm Gilead unsuccessful in patent row over its pre-exposure prophylaxis drug
Banking culture fails customers, Mylan’s HIV self-test kit, and Aeroflot’s budget airline set for Dublin
Business Today: the best news, analysis and comment from ‘The Irish Times’ business desk
Mylan to launch HIV self-test kit in the Irish market
Kit allows patients test for HIV from home, with results coming 15 minutes after testing
HSE could save up to €140m on medicines, says industry group
Spending on high-tech drugs almost doubles to over €660m in nine years
Pharma body calls for more State funding on medicines
Government to save €15m this year as prices fall across 750 drugs
Court refuses injunctions in pharma patent case
Teva sought orders restraining Galway-based Mylan from making MS drug
Political nervousness in Spain and Italy impact on shares
Smurfit Kappa shares slide almost 7% while Aer Lingus owner IAG falls 3.49%
EU proposes waiver for manufacturers of generic drugs
Big pharma companies object to change that would allow generic manufacture of protected medicines for markets outside the bloc
Potential for 25,000 new pharma jobs, US-China trade deal, and Titanic tourism
Business Today: the best news, analysis and comment from ‘The Irish Times’ business desk
Up to 25,000 pharma jobs if EU alters patent rules
Mylan boss calls for waiver on manufacturing of biosimilars
Start-up Nasal Medical signs distribution deal with Mylan
Company’s products will be distributed to more than 2,800 pharmacies
This week: Results from Walt Disney, News Corp and Horizon Pharma
Employment law conference to address ‘increasingly restrictive’ legislation
Bank of Ireland results and unemployment rate
Your upcoming week in business: retail sales and AIB results plus UK housing prices
Broad-based strengths
Barry McCall looks at some of the standout features of Ireland’s life sciences landscape
Two office blocks at Northern Cross for sale separately
Newenham House looking for €16.3m and Newenham Court seeks €9.15m
Gilead loss of generic HIV drug battle a boost for gay community
Generic versions of Truvada that are 60 per cent cheaper are about to hit Irish market
This Week: The events lined up in the business world
There’s the Web Summit in Lisbon, Portugal, plus results from Avis Budget and Trip Advisor
Mylan slashes earnings forecast on US generics price cuts
Earnings undershoot forecasts in second quarter despite acquisitions
Alliance of generic drug makers warns supply reforms needed
Group claims patients may face increasing difficulty accessing lifesaving medicines
Roche shares down after disappointing drug trial results
Pharma group’s breast cancer combination drug only slightly better than older medicine
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices